Dr. Ann Eapen Division of Hematology/Oncology: UC Irvine discusses Immune & Combination Therapies Will be Important for Years Because of tougher, older, and resistant patient populations at MOASCs Spotlight On Hematology in Huntington Beach 2018.
Immune & Combination Therapies Will be Important for Years Because of tougher, older, and resistant patient populations
